Results 91 to 100 of about 48,444 (255)

Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review

open access: yesGlobal Challenges, Volume 9, Issue 5, May 2025.
Silver nanoparticles (AgNPs) exhibit broad‐spectrum antiviral activity by targeting key viral structures and processes. They disrupt viral envelopes, compromising integrity, and bind to nucleocapsids, impairing viral replication. AgNPs also inhibit glycoprotein interactions, preventing viral attachment and entry into host cells.
Ekaterine Mosidze   +8 more
wiley   +1 more source

What we know about ocular manifestations of Ebola

open access: yesClinical Ophthalmology, 2014
Majid Moshirfar,1 Carlton R Fenzl,2 Zhan Li3 1Department of Ophthalmology, Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; 2John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA ...
Moshirfar M, Fenzl CR, Li Z
doaj  

Projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo, as of May 27, 2018. [PDF]

open access: yes, 2018
As of May 27, 2018, 6 suspected, 13 probable and 35 confirmed cases of Ebola virus disease (EVD) had been reported in Équateur Province, Democratic Republic of Congo. We used reported case counts and time series from prior outbreaks to estimate the total
Ackley, Sarah   +17 more
core   +2 more sources

A comparative study of Ebola hemorrhagic fever epidemic trends in three West African countries (Guinea, Liberia and Sierra Leone) -

open access: yes, 2016
Background: From 2014 to 2015, West Africa has faced an unprecedented Ebola outbreak and the most affected three countries were Guinea, Liberia and Sierra Leone.
A. Camara   +7 more
semanticscholar   +1 more source

Ebola viral hemorrhagic fever

open access: yesJournal of Health Policy & Outcomes Research, 2014
Pathogens causing transmissible viral hemorrhagic fevers are therefore classified internationally at the most dangerous hazard level. Most of them may be transmitted through the respiratory tract into human being. For this reason aerosol dissemination of viral pathogens may be considered as biological weapon.
openaire   +2 more sources

Ebola Hemorrhagic Fever as Emerging Zoonotic Disease

open access: yes, 2012
No abstract available for this ...
Elias Alehegn   +2 more
openaire   +3 more sources

Marburg Virus Disease: A Narrative Review

open access: yesHealth Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background and Aims Given the recent deadly outbreaks of the Marburg virus (MARV), in early 2023 in Tanzania and Equatorial Guinea, and the most recent one in Rwanda in 2024, there has been renewed attention across Africa on the threat posed by the re‐emergence of MARV as a growing concern for public health.
Arash Letafati   +4 more
wiley   +1 more source

Ebola Severe Hemorrhagic Fever

open access: yesJournal of Associated Medical Sciences, 2015
-
Kanlaya Wongworapat, Wasana Sirirungsi
doaj  

Improvement of Automatic Hemorrhages Detection Methods Using Shapes Recognition [PDF]

open access: yesJournal of Computer Science 9 (9): 1205-1210, 2013, 2013
Diabetic Retinopathy is a medical condition where the retina is damaged because fluid leaks from blood vessels into the retina. The presence of hemorrhages in the retina is the earliest symptom of diabetic retinopathy. The number and shape of hemorrhages is used to indicate the severity of the disease.
arxiv   +1 more source

Designing and Cloning of the Gene Vaccine Carrying the Viral Haemorrhagic Septicaemia Multi‐Epitope Gene in the pNZ8121 Secretion Vector

open access: yesVeterinary Medicine and Science, Volume 11, Issue 3, May 2025.
Viral haemorrhagic septicaemia virus (VHSV) immunogenic epitopes were used to design a multi‐epitope vaccine with adjuvant. The vaccine's properties, structure and TLR‐4 interaction were analysed via computational methods. Optimized nucleotide sequences were created for Lactococcus lactis expression.
Ramin Shukripour   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy